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ABSTRACT
Objectives: This experiment aims to investigate the apoptosis effect of curcumin and its analogs pentagamavunon-0 (PGV-0) and PGV-1 on normal 
and other cancer cell lines.
Methods: Growth inhibition effect was investigated using the MTT method. Double staining used acridine orange, 2-(4-aminodiphenyl)-6-
indolcarbamidine dihydrochloride and ethidium bromide was performed to determine morphological changes of cells. Detection of PARP, caspase-3, 
PUMA and BAX using a western blot method was conducted to elucidate the apoptosis effect of the compounds.
Results: PGV-1 (2.5 μM) and PGV-0 (5.0 μM) could inhibit T47D-cell growth on 72 h observation, but not for curcumin. DNA staining showed PGV-1 
has the strongest apoptosis induction effect on T47D-cells compared to PGV-0 and curcumin as well. Western blot analysis resulted in cleavage PARP 
(83 kD) on HeLa, T47D, and MCF-7 cells treated with PGV-1 (2.5 µM), PGV-0 (5.0 µM). Curcumin (10.0 µM) just induced apoptosis on T47D-cell and 
MCF-7 cell, but not HeLa cell. Cleavage PARP resulted by apoptosis process in the cell. PGV-1 (2.5 µM) had a stronger apoptosis effect compared to 
PGV-0 (5.0 µM) and curcumin (10.0 µM) based on cleaved PARP result qualitatively. On the normal cell (NH3T3), cells that were treated with the 
compounds resulted in a negative cleavage PARP. This result indicated that the compounds were part of a selectively induced cancer cell line apoptosis 
process.
Conclusion: Curcumin, PGV-0 and PGV-1 could inhibit cell growth by induce apoptosis on cancer cells but not on normal cells, which PGV-1 has 
strongest apoptosis induction effect on cancer cell lines.
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INTRODUCTION
Curcumin, natural compound of Curcuma sp. had been reported to poses 
antiproliferative and induce apoptosis on various cancer cell lines [1]. 
Curcumin is an unstable compound due to the methylene acetone group [2]. 
Pentagamavunon-0 (PGV-0) and PGV-1 (Fig. 1) are analogs of curcumin 
and were synthesized and patented by Samhoedi et al. (2004). Both 
compounds were developed to increase the stability compare to curcumin 
as a parent compound, by omitting methylene between β-diketone group 
of curcumin, which contributed instability of curcumin [2,3].
Previous experiments showed the aromatic region of curcumin 
and analogs play an important role for the activity of curcumin and 
analogs [4,5]. Curcumin as a parent compound has been investigated 
for broad spectrum of biological activities. Many experiments 
showed curcumin could inhibit cancer cell development by inducing 
apoptosis and inhibiting the cell cycle progression as reviewed by 
Ravindran et al. [6].
PGV-0 and PGV-1 have been explored for their biological activities, the 
experiment showed that PGV-0 and PGV-1 possessed a cytotoxic effect [7,8]. 
PGV-1 has a stronger effect to inhibit T47D-cell, which IC50 was 1.74 µg/mL 
compared to PGV-0 and curcumin, which were 9.39 and 24.97 µg/mL, 
respectively [9]. PGV-0 and PGV-1 combined with doxorubicin could inhibit 
MCF-7 by apoptosis induction and cell cycle arrest [10].
PGV-0, PGV-1 and curcumin were indicated to inhibit T47D-cell line 
on G2M phase and induce apoptosis through caspase-3 and caspase-9. 
The inhibition on G2M phase was independent of the apoptosis 
process [11]. A further experiment was needed to investigate the effect 




HeLa, MCF-7, T47D cancer cells and NIH3T3 normal cell were 
provided by Prof. Masashi Kawaichi (NARA Institute of Science 
and Technology, Japan). Cells were cultured in DMEM medium 
and supplemented with 5% fetal bovine serum (Gibco), 100 U/ml 
penicillin and 100 μg/ml streptomycin. Curcumin analogs (PGV-1 and 
PGV-0) were prepared at Gadjah Mada University, and curcumin was 
purchased from E-Merck.
Cells growth test
Harvested cells were seeded onto 96 well plates (3,000 cells in each 
well) in 100.0 µl culture medium, and incubated for 24 hrs in CO2 5%, 
37°C. 100.0 µl sample was added with the final concentration of 
PGV-1, PGV-0 and curcumin were 2.5, 5.0 and 10.0 µM, respectively. 
The cells were incubated for 6, 12, 24, 48 and 72 hrs. After time 
incubation, the medium was discarded and cells were washed using 
PBS pH 7.4 and replaced with 100.0 µl culture medium and added 
with 15.0 µl MTT (5 mg/ml) and followed by a 6 hrs incubation 
period. The formazan was diluted in 10% SDS HCl (0.1%). The result 
was measured using enzyme-linked immunosorbent assay reader 
(550 nm).
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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DNA cell staining
Harvested cells (1.5×104) was seeded on sterile cover slips in 24 well 
plates and incubated to get 50% confluence. Cells were incubated 
with samples for 24 hrs in a 5% CO2 incubator, 37°C. The medium was 
discarded, and cells were added with ethidium bromide 0.5+0.15% 
acridine orange in 95% ethanol solution for 5 minutes. DNA morphology 
was observed under a fluorescent microscope (Zeiss MC-80). The same 
procedure was conducted for staining using 2-(4-aminodiphenyl)-6-
indolcarbamidine dihydrochloride (DAPI) 0.1% in aquabidest.
Western blot analysis
An equal amount of proteins from cell lysates were solubilized five times 
of the sample buffer and electrophoresed in 10-15% sodium dodecyl 
sulfate-polyacrilamide gels and transferred to the polyvinylidene 
difluoride membrane. The membranes were first incubated with 
either primer antibody against cleavage PARP, caspase-3, caspase-7 
were purchased from cell signaling technology) PUMA (proscience), 
BAX (abcham), normalized using tubulin (abcham), and then with a 
horseradish peroxidase-conjugated secondary antibody (cell signaling 
technology). An enhanced chemiluminescence system (Amersham) 
was used to detect the proteins. All methods were adopted from the 
manufacturer with modification.
RESULTS
Inhibition of cell proliferation could be observed by investigating the 
profile of cell growth. The absorbance of formazan that indicated viable 
cells could be converted as a percentage of viable cells and indicated the 
ability of the samples to inhibit cell growth. This experiment showed 
PGV-1 (2.5 μM) and PGV-0 (5.0 μM) could inhibit T47D-cell growth on a 
72 h observation, but not for curcumin (10.0 μM) (Fig. 2). Inhibition of 
cell growth by the compounds is strongly related with the ability of the 
compound to induce apoptosis or cell cycle arrest.
DNA staining of the cells that was induced by the compound using (ethidium 
bromide+acridine orange) and DAPI could be applicated to investigate the 
change of DNA morphology. The result showed PGV-1 has the strongest 
apoptosis induction effect on T47D-cells compared to PGV-0 and curcumin 
as well (Fig. 3). Cells were treated using PGV-1 indicated apoptosis DNA, 
showed by the fragmented DNA (indicated with a red arrow).
The result showed T47D-cells treated with test compounds indicated 
apoptosis of the DNA and some cells showed a multilobular nucleus. 
Cells became bigger and multinucleus, indicated chromatin 
condensation, and failed to divide. The Apoptosis process recruited a 
complex mechanism and should be analyzed further using western blot 
methods, including for the other cell lines.
Western blot analysis was performed on HeLa cell (cervical cancer cell 
invected with human papillomavirus-18) express protein E6 and E7 
that disrupt p53 and pRb suppressor protein [12-14]. The experiment 
also was conducted on MCF-7, a breast cancer cell line that expresses 
normal p53 protein [15], but does not express caspase-3 [16] compared 
to the other breast cancer cell lines type T47D that had mutation on 
p53 gen [17]. The experiment was compared to NIH3T3, normal cell 
omitted from mice fibroblast [12].
Western blot analysis resulted in PARP cleavage (83 kD) on HeLa, 
T47D, and MCF-7 cells treated with PGV-1 (2.5 µM), PGV-0 (5.0 µM). 
Curcumin (10.0 µM) just induced apoptosis on T47D-cell and MCF cell 
but not on HeLa cell (Fig. 4). PARP cleavage resulted by an apoptosis 
process in the cell [18]. These results also show that PGV-1 (2.5 µM) had 
a stronger apoptosis effect compared to PGV-0 (5.0 µM) and curcumin 
(10.0 µM) based on PARP cleavage result qualitatively. On the normal 
cell (NH3T3), cells that were treated with the compounds resulted in a 
negative PARP cleavage. This result indicated that the compounds were 
selectively induced cancer cell line apoptosis process.
Further investigation of PGV-1 showed apoptosis induction on T47D-
cells trough caspase-3 activation independent PUMA and BAX. On the 
other hand, apoptosis induction on MCF-7 cells-even without caspase-3 
expression-was related with PUMA and BAX protein. On HeLa cells, 
apoptosis induction was not related with PUMA and BAX expression 
and did not depend on caspase-3 activation. These findings indicate 
that PGV-1 could induce apoptosis on cancer cell lines with normal p53 
or mutation of p53. Cells that express p53 normally, apoptosis resulted 
through an intrinsic pathway and recruited pro apoptosis protein such 
as PUMA and BAX (Fig. 4).
DISCUSSION
Curcumin, PGV-0 and PGV-1 induced apoptosis on MCF-7 cells. 
Apoptosis induction on MCF-7 cells indicated that curcumin could 
induce apoptosis through accumulation of cells on the G2M phase 
followed by the increase of the p53, p21 expression and release of 
cytochrome C from the mitochondria [19]. This mechanism is similar 
with antimicrotubule drugs, Taxol could induce apoptosis through an 
increase in the level of p53 and p21, which is followed by decreased 
Bcl-2 and induce activation of caspase-9 [20]. This result supported 
the previous research that paclitaxel could induce apoptosis through 
phosphorylated Bcl-2 and increased expression of BAX through 
activated PKA (cyclic adenosine monophosphate-dependent protein 
kinase) pathway [21]. N-phenyl-N’-(2-chloroethyl) ureas had been 
Fig. 2: The effect of pentagamavunon-0 (PGV-0) (5.0 μM), PGV-1 (2.5 μM) and curcumin (10 μM) on T47D cells, (a) absorbance of 
formazan, (b) percentage of viability T47D-cells. PGV-1 (2.5 μM) inhibited stronger compared to PGV-0 (5 μM) and curcumin (10 μM)
a b
Fig. 1: Curcumin analogs. (a) R1=−OCH3, R2=H 
(pentagamavunon-0 [PGV-0]) and R1=R2=−CH3 (PGV-1), were 
monocarbonyl curcumin analogs, previous experiments showed 
that they possess more stable and have better biological activity 
compare to (b) curcumin as the parent compound
a b
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Fig. 4: (A) Pentagamavunon-1 (PGV-1) (5 µg/mL) induced apoptosis cell stronger compared to (B) curcumin (20 µg/mL), (C) PGV-0 
(10 µg/mL) , and (D) control cell. Apoptotic cells were investigated by staining T47D cells using acridine orange: Ethidium bromide (1:1) 
(Line 1) and DAPI (Line 2). Apoptosis cells showed a fragmented nucleus
reported as an antiproliferative on several cancer cell lines that could 
induce apoptosis through translocation of BAX that activate caspase to 
induce apoptosis [22]. Further investigation indicated that PGV-1 could 
elevate PUMA and BAX, pro apoptosis protein, and resulted in PARP 
cleavage as indicator. Apoptosis induction on MCF-7 did not involve 
caspase-3 activation since MCF-7 is not express caspase-3 [16,22-24]. 
This might involve other apoptosis intrinsic pathway that needed other 
protein apoptosis effector.
PGV-1 and PGV-0 induced apoptosis on HeLa cells, but not curcumin. 
Further investigation showed apoptosis on HeLa cells not related with 
level of PUMA, BAX and caspase-3 activation (Fig. 4). It might be caused 
by protein E6 that was expressed by HeLa cells that degraded p53 as 
a transcription factor of PUMA and BAX [13,14]. Apoptosis induction 
on HeLa cells might involve and extrinsic pathway. Taken together, 
curcumin analogs could induce apoptosis on T47D, MCF-7 and HeLa 
cells dependent or independent p53.
Further investigation showed curcumin, PGV-1 and PGV-0 did not induce 
apoptosis on normal cell NIH3T3, PARP cleavage was not shown after 
24 h treatment by those compounds. A higher concentration of PGV-1 
also did not induce apoptosis. After 24 h of being induced by PGV-1, 
NIH3T3 could not activate caspase-3, did not express PUMA, and there 
was no different level of BAX. All of these results indicated curcumin, 
PGV-1 and PGV-0 induced apoptosis on cancer cell selectively. Curcumin 
analogs PGV-0 and PGV-1 are promising to be further developed to 
support cancer therapy.
CONCLUSION
Curcumin, PGV-0 and PGV-1 could inhibit cells growth by induced 
apoptosis on cancer cells but not on normal cells, which PGV-1 has the 
strongest apoptosis induction effect on cancer cell lines.
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